Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2020 16:55 ET | Source: Karolinska Development AB (publ)

Karolinska Developments resultat för tredje kvartalet 2020 påverkas negativt till följd av aktiekursutvecklingen i portföljbolaget Aprea Therapeutics

STOCKHOLM, SVERIGE 30 september 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att bolagets kvartalsresultat kommer att påverkas negativt med cirka SEK 190 miljoner till följd...
September 30, 2020 16:55 ET | Source: Karolinska Development AB (publ)

Karolinska Development's earnings for the third quarter 2020 negatively affected by the share price development in its portfolio company Aprea Therapeutics

STOCKHOLM, SWEDEN – September 30, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the company's quarterly result will be negatively affected by approximately SEK 190...
September 18, 2020 10:05 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag OssDsign stärker patentskyddet på huvudmarknad för OssDsign Cranial PSI

STOCKHOLM, SVERIGE 18 september 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget OssDsign har givits ett godkännande av det amerikanska patentverket (USPTO)...
September 18, 2020 10:05 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company OssDsign strengthens patent coverage for OssDsign Cranial PSI in key market

STOCKHOLM, SWEDEN – September 18, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has received a notice of allowance from the United States Patent...
September 08, 2020 01:30 ET | Source: Karolinska Development AB (publ)

Karolinska Developments finansdirektör lämnar bolaget

STOCKHOLM, SVERIGE 8 september 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att bolagets finansdirektör och vice vd, Fredrik Järrsten, har sagt upp sin anställning. Han...
September 08, 2020 01:30 ET | Source: Karolinska Development AB (publ)

Karolinska Development's CFO is leaving the company

STOCKHOLM, SWEDEN – September 8, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the company's CFO and Deputy CEO, Fredrik Järrsten, has decided to resign from his...
September 02, 2020 03:09 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Umecrine Cognition presenterar utfall från klinisk fas 2a-studie vid AASLD International Liver Meeting

STOCKHOLM, SVERIGE 2 september 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Umecrine Cognition kommer att presentera resultaten i den nyligen genomförda...
September 02, 2020 03:09 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Umecrine Cognition presents results from clinical phase 2a study at AALSD International Liver Meeting

STOCKHOLM, SWEDEN – September 2, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company Umecrine Cognition will present the results from its recently conducted...
August 26, 2020 09:30 ET | Source: Karolinska Development AB (publ)

Promimics samarbetspartner lanserar unikt 3D-printat ryggimplantat efter FDA-godkännande

STOCKHOLM, SVERIGE 26 augusti 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Promimics kund och samarbetspartner INNOVASIS Inc. erhållit ett FDA-godkännande...
August 26, 2020 09:30 ET | Source: Karolinska Development AB (publ)

Promimic’s business partner launches unique 3D-printed implants following FDA approval

STOCKHOLM, SWEDEN – August 26, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that the portfolio company Promimic’s customer and business partner INNOVASIS Inc. has received 501(k)...